Hepatoblastoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Podcasts
• Clinical Trials

Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy
Conditions:   Transitional Cell Tumor;   Hepatoblastoma;   Liver Cancer;   Pediatric Solid Tumor;   Pediatric Cancer Intervention:   Drug: PD-1 inhibitor Sponsor:   RenJi Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2022 Category: Research Source Type: clinical trials

Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors
Conditions:   Osteosarcoma;   Ewing Sarcoma;   Rhabdomyosarcoma;   Relapsed Pediatric Solid Tumor;   Refractory Pediatric Solid Tumor;   Melanoma;   Hepatoblastoma;   Hepatocellular Carcinoma;   Neuroblastoma;   Wilms Tumor Interventions:   Procedure: Cryoablation Therapy;   Drug: Nivolumab;   Drug: Ipilimumab Sponsors:   Children's National Research Institute;   Bristol-Myers Squibb Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 31, 2022 Category: Research Source Type: clinical trials